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Interstitial lung diseases (ILD) are defined as a variety of heterogeneous and
diffuse parenchymal lung disorders associated with significant morbidity and
mortality, sharing similar clinical, radiographical, physiological, or pathological
manifestations. These diseases are generally thought to share a common pattern
of physiologic abnormality, characterized by a restrictive ventilatory defect and
reduced diffusing capacity for carbon monoxide (DLCO).
Conflicting reports have been published regarding small airway function using
more sophisticated testing. Unfortunately, these abnormalities are not specific for any
particular ILD and the magnitude of the changes varies widely from patient to
patient. DLCO typically is reduced in ILD to a greater extent than the lung volume at
which it is measured.
To find distinctive features of the pulmonary function tests results in different
types of ILD.
ILD, pulmonary function tests, obstruction, restriction
We have analyzed the data collected from 40 consecutive patients admitted to
the Institute of Pthisiopneumology, Chisinau, Republic of Moldova, during
January 2019 – February 2020. We have included patients with ILD that are
different from a morphological and pathogenetical point of view and distributed
the patients as follows:
- Sarcoidosis patients – 10 cases,
- Idiopathic pulmonary fibrosis (IPF) patients – 8 cases,
- Nonspecific Idiopatic Insterstitial pneumonia (NSIP) patients – 7 patients,
- Hypersensitivity pneumonitis (HP) patients – 9 subjects
- Histiocytosis (Hx) - 6cases.
All patients have been evaluated by pulmonary function tests, 6MWT, Sa02, MRC
scale for dyspnea, etc.





































COMORBIDITIES PREVALENCE WITHIN SUBGROUPS 
OF THE STUDY COHORT
Arterial Hypertension DM type II Ischemic heart disease PHT





20,0% 33,3% 33,3% 17,5%
87,5% 85,7%
70,0% 66,6% 66,7% 75,0%






















over 60% predicted under 60% predicted
CORRELATION OF CLINICAL PARAMETERS WITH FUNCTIONAL ABNORMALITIES
Air-trapping Restriction DLCO 6MWT
Dyspnea score -0.27 0.4* - 0.57** -0.43**
Smoking status 0.33* -0.22 0.03 0.09
Cough -0.16 0.11 -0.09 0.10
PHT -0.04 -0.15 -0.43** -0.45**
• – correlation is significant at 0.05 level, ** – correlation is significant at 0.01 level, 
PHT – pulmonary hypertension, 
DLCO – diffusing lung capacity for carbon monoxide, 
6MWT – six minute walk test.


































Restriction is the dominant functional abnormality of most ILDs, but it coexists in
various extents with air-trapping, found especially in patients with Hx, HP and
sarcoidosis, this finding is related probably to the bronchiolocentric anatomical
lesions in these entities. DLCO is almost universally decreased in ILDs, with the
lowest levels registered in HP and in IPF patients, while mildly decreased and
even normal values can be found in sarcoidosis and in Hx. IPF, HP and NSIP
patients are more dyspneic, while Hx subjects are less symptomatic. Also, IPF
patients show more comorbidities, while PHT as a complication is more
frequently found in HP. The 6MWT has shown the best results in the NSIP
patients and the worst in HP subgroup. Clinical parameters like dyspnea and PHT
are directly associated with low DLCO and less walked distance at the 6MWT.
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SMOKING STATUS IN PATIENTS IN THE GENERAL 
COHORT AND WITHIN SUBGROUPS
Never smoker Active smoker Ex-smoker
Pairwise comparison of MRC scale of 
dyspnea according to groups of ILD




















DISTRIBUTION OF DLCO ACCORDING TO SEVERITY
normal DLCO mild decrease moderate decrease severe decrease
